Bilaketaren emaitzak - Michael Polydefkis
- Erakusten 1 - 20 emaitzak -- 51
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
Assessment of Epidermal Nerve Fibers nork Gigi J. Ebenezer, Peter Hauer, Christopher H. Gibbons, Justin C. McArthur, Michael Polydefkis
Argitaratua 2007Revisão -
6
Longitudinal assessment of oxaliplatin-induced neuropathy nork Ahmet Z. Burakgazi, Wells A. Messersmith, Dhananjay Vaidya, P. Hauer, Ahmet Höke, Michael Polydefkis
Argitaratua 2011Artigo -
7
Longitudinal Assessment of Small Fiber Neuropathy nork Mohammad Khoshnoodi, Shaun Truelove, Ahmet Z. Burakgazi, Ahmet Höke, Andrew L. Mammen, Michael Polydefkis
Argitaratua 2016Artigo -
8
-
9
-
10
-
11
Diagnosis and treatment of hereditary transthyretin amyloidosis with polyneuropathy in the <scp>United States</scp>: <scp>Recommendations</scp> from a panel of experts nork Chafic Karam, Michelle L. Mauermann, Alejandra González‐Duarte, Michelle Kaku, Senda Ajroud‐Driss, Thomas H. Brannagan, Michael Polydefkis
Argitaratua 2024Artigo -
12
-
13
Treatment response and neurofilament light chain levels with long-term patisiran in hereditary transthyretin-mediated amyloidosis with polyneuropathy: 24-month results of an open-l... nork Simina Ticau, Emre Aldinc, Michael Polydefkis, David Adams, Teresa Coelho, Mitsuharu Ueda, Cecilia Hale, Joshua R. Vest, Paul Nioi
Argitaratua 2023Artigo -
14
-
15
-
16
LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection nork Malcolm S. Duthie, Maria T. Peña, Gigi J. Ebenezer, Thomas P. Gillis, Rahul Sharma, Kelly Cunningham, Michael Polydefkis, Yumi Maeda, Masahiko Makino, Richard W. Truman, Steven G. Reed
Argitaratua 2018Artigo -
17
Neuropathic symptoms with SARS-CoV-2 vaccination nork Farinaz Safavi, Lindsey P. Gustafson, Brian Walitt, Tanya Lehky, Sara Dehbashi, Amanda Wiebold, Yair Mina, Susan Shin, Baohan Pan, Michael Polydefkis, Anne Louise Oaklander, Avindra Nath
Argitaratua 2022Pré-impressão -
18
Evaluation of disease progression in patients with ATTR amyloidosis with cardiomyopathy following treatment with patisiran: post-hoc analysis of the APOLLO-B study nork Thibaud Damy, Zubair Shah, Brian Drachman, Pedro Vellosa Schwartzmann, Cláudio Tinoco Mesquita, Michael Polydefkis, Laura Obici, Patrick Y. Jay, Shaun Bender, Kelley E. Capocelli, Mazen Hanna
Argitaratua 2023Artigo -
19
Race and Socioeconomic Status Impact Diagnosis and Clinical Outcomes in Transthyretin Cardiac Amyloidosis nork Bairavi Shankar, Lisa R. Yanek, Artrish Jefferson, Vivek Jani, Emily Brown, Daniel Tsottles, Jennifer Barranco, Serena Zampino, Mark J. Ranek, Kavita Sharma, Michael Polydefkis, Joban Vaishnav
Argitaratua 2024Artigo -
20
Comparison of efficacy outcomes with Vutrisiran vs. Patisiran in hATTR amyloidosis with polyneuropathy: post-hoc analysis of the HELIOS-A study nork Michael Polydefkis, Frank Birklein, Yoshiki Sekijima, Davide Pareyson, Márcia Waddington‐Cruz, Raphael Santa Rosa Sayegh, David Danese, Kelley E. Capocelli, Madeline Merkel, Chongshu Chen, Joshua R. Vest, David Adams
Argitaratua 2023Artigo
Bilaketa egiteko lanabesak:
Antzeko gaiak
Medicine
Internal medicine
Amyloidosis
Transthyretin
Polyneuropathy
Pathology
Endocrinology
Biology
Gastroenterology
Surgery
Diabetes mellitus
Disease
Nursing
Physical therapy
Quality of life (healthcare)
Alternative medicine
Anatomy
Neuroscience
Peripheral neuropathy
Placebo
Anesthesia
Clinical trial
Gene
Genetics
Oncology
Psychiatry
Biochemistry
Biopsy
Confidence interval
Environmental health